PRLX Announces Immediate Availability of its Good Health Outcomes Remote Patient Monitoring Mobile Application
12 March 2020 - 9:35PM
InvestorsHub NewsWire
Parallax Health Management
Announces Immediate Availability of its Good Health Outcomes Remote
Patient Monitoring Mobile Application for Doctors and Their
Patients Within the United States
$8.3 Billion in Federal
Emergency Funding from U.S. Congress Combined with Private
Insurance Reimbursement Commitments Gives Boost to Telehealth
Programs Addressing the COVID-19 Pandemic
NEW YORK, NY -- March 12, 2020 -- InvestorsHub NewsWire
-- Parallax Health Sciences,
Inc. (PRLX)
(''Parallax'' or the ''Company''), an outcome-driven connected
healthcare company, today announced its wholly owned subsidiary
Parallax Health Management, Inc. focused on Remote Patient
Monitoring (“RPM”) has the Health Insurance Portability and
Accountability Act (“HIPAA”) compliant, proprietary and patented
Good Health Outcomes™ platform now available for doctors and their
patients within the United States. The scalable remote patient
monitoring platform, available now from the Apple IOS and Google
Play mobile application stores, is supported by Amazon’s AWS Secure
Healthcare hosting centers and enables real-time secure audio and
video conferencing, data capture, transmission and biometric
monitoring data including temperature and respiratory monitoring
devices. The scalable platform has been provisioned to accommodate
the COVID-19 (coronavirus disease 2019) and can be used securely by
authorized care providers to provide approved telehealth
services.
Nathaniel Bradley, President of Parallax Health Management,
stated, “At a news conference on Monday, March 9th, Seema Verma,
the Administrator of the Centers for Medicare and Medicaid Services
(“CMMS”) praised the Government’s efforts to expand the use of
Telemedicine under Medicare, which is the Federal Program for
people 65 years and older.” Mr. Bradley, who also serves as Chief
Technology Officer of Parallax Health Sciences, went on to say,
“The addition of private payers and their commitment to reimburse
for approved telehealth services will allow patients to be
monitored and to receive secure and robust telemedicine services
supported through our Good Health Outcomes™ platform.”
Good Health Outcomes™ enables a unique offering that includes
proprietary Fotodigm® data capture technology that enables the
secure capture of data from any FDA approved monitoring device. It
also features encrypted data management systems and seamless
systems integration with any secure electronic medical record
(“EMR”) and medical billing platforms. Our Good Health
Outcomes™ is the only mobile application system to feature patented
data-driven outcomes technology known as reliable evidenced based
outcomes optimization technology, (“R.E.B.O.O.T.”) that allows for
automated interventions and mobile alerts.
From what is understood by infectious disease experts, the
COVID-19 (coronavirus disease 2019) is different due to the unknown
factors surrounding transmission and its effects on patients,”
stated Paul Arena, Chief Executive Officer for Parallax Health
Science. Mr. Arena continued, “the coronavirus is still being
figured out and there have been a significant number of deaths,
given the high level of uncertainty surrounding this pandemic it is
scary to both patients and the general public. Our healthcare
solutions and ability to remotely diagnose and monitor patients
provides healthcare providers with tools to become less
challenged and to make accurate recommendations even when there are
still many unknowns facing the mass population. Yesterday we
announced our strategic initiative for the creation of a rapid
screening test on our VT-1000 diagnostics device for the Covid-19
that when available soon will produce results within 15
minutes. Our integrated remote patient monitoring and
diagnostic platform can be useful to assess and comfort patients in
alternative settings such as their home, and also for determining
which patients need to be seen in the hospital or if urgent care is
appropriate. Our Good Health Outcomes™ platform can enable
healthcare providers to treat isolated patients and help to prevent
the spread of what is becoming an extremely contagious virus.”
Any Doctor, Critical Access Hospital, Hospital or nursing
operation can download and register for free immediately at the
Parallax website:
https://goodhealthoutcomes.com/good-health-outcomes
About Parallax Health Sciences
Parallax Health Sciences is a leading-edge technology,
outcome-driven telehealth company that allows for cost-effective
remote diagnosis, treatment, and monitoring of patients through
proprietary platforms of integrated products and services. The
Company's interoperable novel applications provide patients
point-of-care testing and monitoring with information communicated
via internet-based mobile phone applications that are agnostic as
to operating system and are built on highly sophisticated data
analytics. Information is retrieved in real-time by physicians who
are monitoring patients with chronic diseases or through biometric
feedback for health-related behavior modification, and is automated
for integration into electronic health records. The Company's
products and offerings capitalize on the digital transformation in
healthcare for improved patient compliance, diagnosis and
treatment, and support healthcare system cost savings and
efficiencies. For more information, please
visit www.parallaxhealthsciences.com or www.parallaxcare.com.
Investor
Contact:
Paul Arena,
CEO
paul@parallaxcare.com
cell
404-915-8449
Parallax Health Sciences (CE) (USOTC:PRLX)
Historical Stock Chart
From May 2024 to Jun 2024
Parallax Health Sciences (CE) (USOTC:PRLX)
Historical Stock Chart
From Jun 2023 to Jun 2024